Ballad Health And Varian, A Health Company Based In California, Have Announced A 10-Year, $260 Million Collaboration Aimed At Improving Cancer Care In Northeast Tennessee And Southwest Virginia. The Agreement Includes Acquiring Advanced Equipment, Technology, And Software To Enhance Oncology Treatment Services. The Head Of Varian, Arthur Kaindl, Emphasized The Partnership’s Goal Is To Expand Access To World-Class Quality Care For Everyone In The Region. This Investment, Approved By Ballad Health’s Board Of Directors, Represents A Significant Commitment To Advancing Healthcare Technology And Patient Care In The Area.
